Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children

Liposomal amphotericin B (LAmB) is widely used in the treatment of invasive fungal disease (IFD) in adults and children. There are relatively limited pharmacokinetic (PK) data to inform optimal dosing in children that achieves systemic drug exposures comparable to those of adults. Our objective was...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Antimicrob Agents Chemother
Prif Awduron: Lestner, Jodi M., Groll, Andreas H., Aljayyoussi, Ghaith, Seibel, Nita L., Shad, Aziza, Gonzalez, Corina, Wood, Lauren V., Jarosinski, Paul F., Walsh, Thomas J., Hope, William W.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2016
Pynciau:
Pharmacology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119015/
https://ncbi.nlm.nih.gov/pubmed/27697762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01427-16
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg